St. Antonius-Hospital Gronau GmbH
- Address
- lock Available on a paid plan
Analytical, Diagnostic and Therapeutic Techniques and Equipment
At St. Antonius-Hospital Gronau GmbH, research in urology includes work on diagnostic imaging and advanced medical techniques for prostate cancer. The studies focus on improving how clinicians detect and assess disease spread, especially in men with newly diagnosed high-risk forms of the disease.
- Evaluating PSMA PET-CT for more accurate detection of pelvic lymph node metastases
- Improving diagnostic confidence in high-risk and very-high-risk prostate cancer
- Comparing imaging findings with histology to confirm disease staging
This area of research aims to strengthen early staging and support better treatment planning for patients with prostate malignancies.
Diseases of the Urinary System and Male Reproductive Organs
The site is also studying prostate cancer as a major urologic oncology focus, including high-risk localized and locally advanced disease. These trials explore whether adding new hormonal treatment approaches can improve outcomes before and after surgery.
- Testing a combination of androgen deprivation therapy and apalutamide for better disease control
- Assessing whether treatment can improve pathologic complete response and metastasis-free survival
- Supporting decisions around treatment effectiveness in prostate cancer care
This research reflects a broader effort to refine therapy for aggressive prostate tumors and improve long-term outcomes for patients treated at the hospital.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in St. Antonius-Hospital Gronau GmbH
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of [18F]PSMA-1007 PET/CT Imaging for Detecting Pelvic Nodal Metastases in High-Risk Prostate Cancer Patients | Abx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GmbH | Phase III | Recruiting | Jun 2024 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| (2S)-2-[[(1S)-1-Carboxy-5-[[(2S)-2-[[4-[[[(2S)-4-Carboxy-2-[[(2S)-4-Carboxy-2-[(6-(18F)Fluoranylpyridine-3-Carbonyl)Amino]Butanoyl]Amino]Butanoyl]Amino]Methyl]Benzoyl]Amino]-3-Naphthalen-2-Ylpropanoyl]Amino]Pentyl]Carbamoylamino]Pentanedioic Acid | 1 | Unknown | 2024-06-05 | 2024-06-05 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.